If you have been diagnosed with PMDD, or you are working through a careful evaluation toward that diagnosis, the next question is what to actually do about it. The good news is that PMDD responds well to several medication options, and the evidence base is solid. The harder part is sorting through which medication, in which dose, and on which schedule fits your specific situation.
This article compares the main categories used for PMDD medication: SSRIs (the first-line treatment, with three different dosing strategies), hormonal birth control, and a smaller set of other options. It also covers what has weak evidence and is probably not worth pursuing, so you do not waste months on approaches that the research does not support.
How PMDD medication works (the brief science)
PMDD is a cyclical mood disorder. Hormone levels are normal; the brain’s response to those normal hormonal fluctuations is what differs. Two mechanisms in particular shape why specific medications work.
The first is serotonin sensitivity. People with PMDD appear to have heightened reactivity to cyclical shifts in serotonin function, which is why SSRIs (which act on the serotonin system) are the most effective medication category for PMDD. Notably, SSRIs work faster for PMDD than for major depression, often within days rather than weeks, which makes flexible dosing strategies possible.
The second is allopregnanolone, a neurosteroid produced when progesterone is metabolized. Allopregnanolone normally has a calming effect on the brain via GABA-A receptors, but in people with PMDD this calming effect appears disrupted, contributing to the anxiety, irritability, and emotional volatility that surface in the luteal phase. Hormonal contraceptives that suppress ovulation can reduce these cyclical neurosteroid shifts entirely, which is why they help some people with PMDD.
These two mechanisms also explain why some commonly tried approaches (progesterone supplementation, diuretics, anti-anxiety medications alone) do not address the actual underlying problem. The next sections cover what works in detail.
For a deeper explanation of the condition itself, see What Is PMDD: Causes, Symptoms, and When to See a Doctor.
SSRIs: the first-line PMDD medication
Selective serotonin reuptake inhibitors are the first-line medication treatment for PMDD across all major treatment guidelines. They have the strongest evidence base, the fastest onset of action, and the most flexibility in how they can be prescribed.
Three SSRIs hold specific FDA approval for PMDD: fluoxetine (marketed as Prozac for depression and Sarafem for PMDD), sertraline (Zoloft), and paroxetine controlled-release (Paxil CR). Other SSRIs, including citalopram (Celexa) and escitalopram (Lexapro), are commonly used off-label for PMDD with similar efficacy in clinical practice, even though they do not hold the specific FDA indication. The choice between SSRIs is typically based on side effect profile, patient history, and prescriber familiarity rather than a clear efficacy difference.
Doses for PMDD are typically lower than doses used to treat depression. Fluoxetine for PMDD is often started at 10 to 20 mg, sertraline at 25 to 50 mg, and paroxetine CR at 12.5 mg. Some patients require higher doses for full symptom control, but the lower-dose starting point reflects how rapidly SSRIs work in PMDD.
Common side effects include nausea (usually in the first two weeks), changes in sleep, sexual side effects (decreased libido, delayed orgasm), and reduced appetite. Side effects are often the deciding factor in which SSRI to try and which dosing strategy to use. The dosing strategy is where PMDD treatment differs most from depression treatment, which is the next section.
Three ways SSRIs are dosed for PMDD
This is where PMDD medication gets interesting. Unlike depression, which requires continuous daily dosing for the SSRI to work, PMDD allows for three different dosing strategies, each with trade-offs.
Continuous dosing means taking the SSRI every day throughout the cycle, the same way it would be prescribed for depression. The advantages are the simplest schedule (no tracking required), steady serotonin levels, and the strongest evidence for severe PMDD. The disadvantages are continuous exposure to side effects, including sexual side effects that may not be worth tolerating for two weeks of symptom relief.
Luteal-phase dosing means taking the SSRI only during the luteal phase of the cycle, typically starting about 14 days before menstruation is expected (around ovulation) and stopping when menstruation begins or a few days into it. This works because SSRIs in PMDD produce relief within days rather than the four-to-six weeks needed for depression. The advantages are reduced overall side effect burden, no exposure during the symptom-free follicular phase, and potentially better tolerability for long-term treatment. The disadvantages are the need to track your cycle accurately, the difficulty for people with irregular cycles, and slightly less complete symptom coverage in some studies.
Symptom-onset dosing means taking the SSRI only when symptoms appear in a given cycle, typically a few days before menstruation. This is the newest strategy and the one with the most mixed evidence. A large clinical trial showed only modest benefit over placebo on the primary outcome measure, though symptom-specific improvements (particularly for anger and irritability) were noted. Symptom-onset dosing requires predictable symptoms and is generally a second-tier option after continuous or luteal-phase dosing has been tried.
The choice between these three is individual. Continuous dosing is the standard for severe PMDD, particularly when symptoms include suicidal thoughts or significant functional impairment. Luteal-phase dosing is reasonable for moderate PMDD with predictable cycles. Symptom-onset dosing is a third-line option for specific situations. A research-informed prescriber should explain the trade-offs and let you participate in the choice rather than defaulting to whichever schedule they prescribe most often.
The MGH Center for Women’s Mental Health maintains a useful clinical overview of the evidence for symptom-onset dosing specifically, for readers who want a deeper look at this comparison.
Hormonal birth control for PMDD
The second main category of PMDD medication is hormonal contraception. The logic is straightforward: PMDD is triggered by cyclical hormonal shifts, so suppressing those shifts can suppress the symptoms.
Only one specific formulation holds FDA approval for PMDD: a combined oral contraceptive containing drospirenone and ethinyl estradiol (marketed as Yaz, with similar formulations available as generics). The drospirenone in this formulation has anti-androgenic and anti-mineralocorticoid properties that distinguish it from progestins in other combined oral contraceptives, and it has the strongest evidence for PMDD among hormonal options.
Hormonal contraceptives can be used in standard cyclic dosing (with a placebo week each month, producing a withdrawal bleed) or in continuous dosing (skipping the placebo week entirely, suppressing menstruation and the cyclical hormonal shifts). Continuous dosing is increasingly used for PMDD because it more completely suppresses the cyclical trigger. Some prescribers shorten the placebo week to two days rather than seven (sometimes called “24/4” formulations, which Yaz is) to reduce the hormone-free interval that can produce a mini-PMDD episode each month.
Hormonal contraceptives are not universally helpful. Some people with PMDD feel worse on combined oral contraceptives, particularly during the first few cycles. Progestin-only contraceptives (the mini-pill, hormonal IUDs) have weaker evidence and a less predictable effect on PMDD. If you have tried hormonal contraception and felt worse, that is useful information but does not necessarily mean all hormonal approaches will affect you the same way.
The decision between starting with an SSRI or starting with a hormonal contraceptive depends on several factors. Contraceptive needs, reproductive plans, severity of symptoms, history of mood response to hormones, and patient preference all matter. For someone who needs contraception anyway, a drospirenone-containing oral contraceptive is a reasonable first try. For someone with severe PMDD or a history of mood worsening on hormonal birth control, an SSRI is usually the better starting point.
Combination treatments and other options
When SSRIs alone or hormonal contraceptives alone do not produce adequate relief, several other approaches exist.
Combination treatment with an SSRI and a hormonal contraceptive is common in clinical practice. The two approaches act on different mechanisms (serotonin and ovulation suppression), and the combination can produce better symptom control than either alone for some patients.
SNRIs, particularly venlafaxine (Effexor), have evidence for PMDD and are sometimes used when SSRIs have not been tolerated or have not produced adequate response. The evidence base is smaller than for SSRIs, but venlafaxine is a reasonable option for some patients.
Spironolactone can help with physical PMDD symptoms (bloating, breast tenderness) at doses around 50 to 100 mg taken in the luteal phase, though it does not address the emotional symptoms.
Cognitive behavioral therapy has reasonable evidence as an adjunct treatment for PMDD, particularly for managing the distress and functional impairment that comes with cyclical symptoms. CBT does not replace medication for severe PMDD but adds meaningful benefit alongside it.
GnRH agonists (medications that temporarily suppress ovarian hormone production, producing a medical menopause) are reserved for severe, treatment-resistant PMDD. They are highly effective at eliminating symptoms but produce menopausal side effects (hot flashes, bone density loss, mood changes) and typically require add-back hormone therapy. This is a niche option for specific cases and is usually managed by reproductive psychiatry or gynecology specialists rather than initiated as a first-line treatment.
What does not work (or has weak evidence) for PMDD
Save yourself the time and money these often cost without producing real results.
Progesterone supplementation does not work for PMDD despite being widely marketed and recommended in some functional medicine circles. The underlying problem in PMDD is not a progesterone deficiency, so adding more progesterone does not address the mechanism. Multiple randomized controlled trials have shown progesterone is not effective for PMDD.
Diuretics can reduce bloating and water retention but do not address the emotional symptoms that define PMDD. They have a symptomatic role at most.
Vitamin B6, calcium, and magnesium have modest evidence for PMS symptoms and minimal evidence for PMDD specifically. Calcium supplementation (1,200 mg per day) has the strongest evidence among these and is sometimes recommended as an adjunct, but none of these are an adequate stand-alone treatment for moderate-to-severe PMDD.
Anti-anxiety medications alone (benzodiazepines, buspirone) can reduce specific symptoms (acute anxiety, sleep difficulty) but do not address the underlying PMDD mechanism. They are not first-line treatments and carry their own risks, particularly for benzodiazepines and dependence.
Herbal remedies (chasteberry, evening primrose oil, St. John’s Wort) have mixed and generally weak evidence for PMDD specifically. Chasteberry has the strongest of these (modest evidence for PMS), but none are an alternative to evidence-based medications for moderate-to-severe PMDD.
Antidepressants other than SSRIs and SNRIs (bupropion, mirtazapine, tricyclics) have minimal evidence for PMDD because they do not act primarily on the serotonin system. Only serotonergic antidepressants reliably work for PMDD.
If you have spent months trying lifestyle changes, supplements, and progesterone and you are still suffering, the evidence is not on the side of those approaches for severe PMDD. The medications that work have specific mechanisms, and there is no good reason to delay an evidence-based option.
How to know which PMDD medication is right for you
The right starting point depends on several factors that your prescriber should walk through with you.
Severity of symptoms. Severe PMDD, particularly with suicidal thoughts or significant functional impairment, usually starts with continuous SSRI dosing because of the strongest evidence and the most complete symptom coverage.
Reproductive plans. If you are trying to conceive, hormonal contraception is off the table and an SSRI is the typical choice (with careful conversation about the SSRI’s safety profile during conception and pregnancy). If you need contraception anyway, a drospirenone-containing combined oral contraceptive is a reasonable first option.
Previous response to antidepressants. If you have taken an SSRI before for depression or anxiety and responded well, that SSRI is a reasonable first try for PMDD. If you had significant side effects on a particular SSRI, your prescriber should consider a different one.
Previous response to hormonal birth control. If you have used a combined oral contraceptive in the past and felt worse on it, an SSRI is usually the better starting point.
Comorbid conditions. PMDD frequently co-occurs with depression, anxiety, ADHD, and trauma-related conditions. Treating these alongside PMDD often improves overall outcomes and shapes medication choice.
Side effect tolerance. Sexual side effects from SSRIs, weight changes from hormonal contraceptives, sedation from various medications: these vary by patient, and a conversation about what you can and cannot tolerate is part of choosing well.
For more on what comprehensive PMDD treatment involves in our practice, see the PMDD treatment page and the premenstrual dysphoric disorder care overview.
When to take the next step
PMDD is treatable, and the medication options have meaningful evidence behind them. The hard part is usually finding a prescriber who will take the time to understand your specific symptom pattern, walk you through the trade-offs, and adjust the plan based on how you respond.
Gimel Health provide precision psychiatry and medication management for patients in New Jersey (in-person at Fort Lee) and New York (telehealth). Initial consultations are 50 minutes and cover your full PMDD picture: symptom pattern, prior medication trials, reproductive plans, and any conditions that may be present alongside PMDD.
For trusted general reference on PMDD treatment, the MGH Center for Women’s Mental Health maintains a high-quality clinical resource. If you are still working out whether what you experience is PMDD or PMS, our PMDD vs PMS comparison guide covers the distinction in detail.
